Cargando…
Association of HLA class I type with prevalence and outcome of patients with acute myeloid leukemia and mutated nucleophosmin
Acute myeloid leukemia with mutated nucleophosmin (NPMc+ AML) forms a distinct AML subgroup with better prognosis which can potentially be associated with immune response against the mutated nucleophosmin (NPM). As the T-cell-mediated immunity involves antigen presentation on HLA class I molecules,...
Autores principales: | Kuželová, Kateřina, Brodská, Barbora, Schetelig, Johannes, Röllig, Christoph, Ráčil, Zdeněk, Walz, Juliane Stickel, Helbig, Grzegorz, Fuchs, Ota, Vraná, Milena, Pecherková, Pavla, Šálek, Cyril, Mayer, Jiří |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6296532/ https://www.ncbi.nlm.nih.gov/pubmed/30557403 http://dx.doi.org/10.1371/journal.pone.0204290 |
Ejemplares similares
-
Altered HLA Class I Profile Associated with Type A/D Nucleophosmin Mutation Points to Possible Anti-Nucleophosmin Immune Response in Acute Myeloid Leukemia
por: Kuželová, Kateřina, et al.
Publicado: (2015) -
Localization of AML-related nucleophosmin mutant depends on its subtype and is highly affected by its interaction with wild-type NPM
por: Brodská, Barbora, et al.
Publicado: (2017) -
High PD-L1 Expression Predicts for Worse Outcome of Leukemia Patients with Concomitant NPM1 and FLT3 Mutations
por: Brodská, Barbora, et al.
Publicado: (2019) -
NSC348884 cytotoxicity is not mediated by inhibition of nucleophosmin oligomerization
por: Šašinková, Markéta, et al.
Publicado: (2021) -
NPM1 and DNMT3A mutations are associated with distinct blast immunophenotype in acute myeloid leukemia
por: Kuželová, Kateřina, et al.
Publicado: (2022)